A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.
Media Relations Manager (Enterprise)
T: 020 7679 9063
ENTERPRISE SUCCESS STORIES
The evolution of mobile has been one of the most important technological developments of the 21st century. For anyone getting to grips with it, its breadth, rate of growth and pace of change can seem daunting. The Mobile Academy, an exciting new collaboration between UCL and Mobile Monday London, is here to help people get – and stay – up to speed with the mobile world. More...
IN THE PRESS
UCL graduate Arthur Kay, co-founder of the coffee grounds recycling company bio-bean, has won the Postcode Lottery Green Challenge 2014, winning a prize of €500,000 towards the expansion of his business. More...
We are pleased to confirm that Professor Stephen Caddick has been appointed to the new position on the LEP for a representative of London’s Higher Education sector.
New ventures are started for many reasons, with one of the most common routes beginning with someone doing a job they like in a big company and thinking they want to do it for themselves, but where do they go from there, asks Timothy Barnes, Director of UCL Enterprise Operations and UCL Advances. More...